We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Stroke and Recent Myocardial Infarction, Reduced Left Ventricular Ejection Fraction, Left Ventricular Thrombus, and Wall Motion Abnormalities

    Purpose of Review

    To review the evidence regarding stroke and recent myocardial infarction (MI), reduced left ventricular ejection fraction, left...

    Ana Catarina Fonseca in Current Cardiology Reports
    Article Open access 11 December 2023
  2. Left ventricular geometry characteristics and clinical outcomes in hemodialysis patients with heart failure with preserved ejection fraction

    Background

    The relationships among left heart remodeling, cardiac function, and cardiovascular events (CEs) in patients with heart failure (HF) with...

    Yi Zhang, **aofei Guo, ... **aomei Huang in BMC Cardiovascular Disorders
    Article Open access 27 June 2024
  3. Low-flow in aortic valve stenosis patients with reduced ejection fraction does not depend on left ventricular function

    Background

    Patients with severe aortic stenosis (AS) and reduced left ventricular ejection fraction (LVEF) can be distinguished into high- (HG) and...

    Svante Gersch, Torben Lange, ... Karl Toischer in Clinical Research in Cardiology
    Article Open access 18 January 2024
  4. Native T1 high region and left ventricular ejection fraction recovery in patients with dilated cardiomyopathy

    Native T1 map** is used to assess myocardial tissue characteristics without gadolinium contrast agents. The focal T1 high-intensity region can...

    Mayu Yazaki, Takeru Nabeta, ... Junya Ako in The International Journal of Cardiovascular Imaging
    Article Open access 08 June 2023
  5. Revascularization in Ischemic Heart Failure with Reduced Left Ventricular Ejection Fraction

    Purpose of Review

    Coronary artery disease (CAD) is estimated to account for over 60% of heart failure (HF) patients and is associated with worse...

    Pawel Gasior, Wojciech Wojakowski, Elvin Kedhi in Current Cardiology Reports
    Article 03 April 2023
  6. Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy

    Background

    The right ventricle (RV) in hypertrophic cardiomyopathy (HCM) tends to be neglected, as previous efforts have predominantly focused on...

    Masliza Mahmod, Betty Raman, ... Stefan Neubauer in Journal of Cardiovascular Magnetic Resonance
    Article Open access 13 June 2022
  7. Segmental and global myocardial work in hypertensive patients with different left ventricular ejection fraction: what’s the role of the apex played?

    We investigated myocardial work in hypertension (HT) among patients with different left ventricular ejection fraction (LVEF) to analyze the...

    Huimei Huang, Qinyun Ruan, ... Liyun Fu in The International Journal of Cardiovascular Imaging
    Article 31 May 2023
  8. NT-proBNP as predictor of major cardiac events after renal transplantation in patients with preserved left ventricular ejection fraction

    Background

    For the improvement of outcome after renal transplantation it is important to predict future risk of major adverse cardiac events as well...

    Sebastian Schwab, Daniel Pörner, ... Rainer P. Woitas in BMC Nephrology
    Article Open access 11 February 2023
  9. Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure

    Sacubitril/valsartan has become an important first-line drug for symptomatic heart failure (HF) patients, especially with left ventricular (LV)...

    Yu Nishihara, Makoto Nishimori, ... Hidekazu Tanaka in Heart and Vessels
    Article 21 September 2023
  10. Evaluation the relationship between myocardial fibrosis and left ventricular torsion measured by cardiac magnetic resonance feature-tracking in hypertrophic cardiomyopathy patients with preserved ejection fraction

    The relationship between left ventricular (LV) torsion and myocardial fibrosis (MF) in hypertrophic cardiomyopathy (HCM) patients with preserved...

    Ying Zhong, Ce Li, ... Guan Wang in The International Journal of Cardiovascular Imaging
    Article 07 March 2024
  11. Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction?

    Heart failure (HF) with preserved ejection fraction (HFpEF) causes a progressive limitation of functional capacity, poor quality of life (QoL) and...

    Mauro Riccardi, Antonio M. Sammartino, ... Matteo Pagnesi in Heart Failure Reviews
    Article 18 May 2023
  12. Left ventricular systolic dyssynchrony: a novel imaging marker for early assessment of myocardial damage in Chinese type 2 diabetes mellitus patients with normal left ventricular ejection fraction and normal myocardial perfusion

    Objectives

    Myocardial damage is the important cause of heart failure (HF) in type 2 diabetes mellitus (T2DM), which is difficult to early diagnose,...

    Yufeng Wang, Wenji Yu, ... Yuetao Wang in Journal of Nuclear Cardiology
    Article 28 February 2023
  13. Left atrial strain as a predictor of left ventricular filling pressures in coronary artery disease with preserved ejection fraction: a comprehensive study with left ventricular end-diastolic and pre-atrial contraction pressures

    Assessing left ventricular (LV) filling pressure (LVFP) is challenging in patients with coronary artery disease (CAD) and preserved LV ejection...

    Gustavo Nishida, Antonio Amador Calvilho Junior, ... Sergio Luiz Navarro Braga in The International Journal of Cardiovascular Imaging
    Article 04 September 2023
  14. Ventricular-atrial coupling in subjects with normal, preserved, and reduced left ventricular ejection fraction: insights from cardiac magnetic resonance imaging

    Objectives

    To assess the correlation between LA and LV strain measurements in different clinical scenarios and evaluate to what extent LA deformation...

    Di Zhou, Yining Wang, ... Minjie Lu in European Radiology
    Article 15 June 2023
  15. Correlating decline in left ventricular ejection fraction and longitudinal strain in pediatric cancer patients

    Purpose

    Left ventricular ejection fraction (LVEF) is routinely used to monitor cardiac function in cancer patients. Global longitudinal strain (GLS)...

    Aura A Sanchez Mejia, Ricardo H Pignatelli, ... Robert W Loar in The International Journal of Cardiovascular Imaging
    Article 21 December 2022
  16. Left ventricular and atrial myocardial strain in heart failure with preserved ejection fraction: the evidence so far and prospects for phenoty** strategy

    Background

    Heart failure with preserved ejection fraction (HFpEF) represents a significant proportion of heart failure cases. Accurate diagnosis is...

    Mariane Higa Shinzato, Natasha Santos, ... Renato A. Hortegal in Cardiovascular Ultrasound
    Article Open access 04 March 2024
  17. Superoxide dismutases: marker in predicting reduced left ventricular ejection fraction in patients with type 2 diabetes and acute coronary syndrome

    Aim

    To examine the prognostic value of superoxide dismutase (SOD) activity for monitoring reduced left ventricular ejection fraction(LVEF)in the...

    **u-Yun Jiang, Qing Chen, ... Qing-Bo Guan in BMC Cardiovascular Disorders
    Article Open access 03 April 2024
  18. Long-term outcomes after aortic valve surgery in patients with aortic regurgitation with preserved ejection fraction and left ventricular dilation

    Objectives

    This study aims to assess the long-term outcomes and prognostic predictors of asymptomatic patients with severe aortic regurgitation (AR)...

    **ngli Fan, **angyang Xu, ... Yongbing Chen in General Thoracic and Cardiovascular Surgery
    Article 19 July 2022
  19. Effect of dapagliflozin on ventricular repolarization in patients with heart failure with reduced ejection fraction

    Whether sodium–glucose cotransporter-2 inhibitors (SGLT2is) reduce ventricular arrhythmias and sudden cardiac death is controversial. Ventricular...

    Masaaki Nakase, Kazuyuki Yahagi, ... Kengo Tanabe in Heart and Vessels
    Article 12 September 2023
  20. Rationale and Design of Prospective, Multicenter, Double-Arm Clinical Trial to Investigate the Efficacy of Tofogliflozin on Left Ventricular Diastolic Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes Mellitus (TOP-HFPEF Trial)

    Background

    Recent large clinical trials have revealed that sodium–glucose cotransporter 2 (SGLT2) inhibitors improve cardiovascular outcomes not only...

    Shin Ito, Yuri Nakajima, ... Masafumi Kitakaze in Cardiovascular Drugs and Therapy
    Article 10 May 2024
Did you find what you were looking for? Share feedback.